It significantly lowered the AST & ALT levels in both treated groups compared to the untreated AKI group, confirming previous studies correlating AKI with hepatic dysfunction (Fadillioglu et al., 2008; Park et al., 2012). The gene discussed is GPT; the disease is acute kidney injury.